Abnormalities of Cone and Rod Function

Retina Fifth Edition

Volumn 2, Issue , 2012, Pages 899-906

  Wu, David M ^a   Fawzi, Amani A ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84906798058     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4557-0737-9.00044-8     Document Type: Chapter

References (88)

1. Sharpe LT, Stockman A, Jagle H, et al. Opsin genes, cone photopigments, and colour blindness. Color vision: From genes to perception 1999, 3-52. Cambridge University Press, Cambridge. K.S. Gegenfurtner, L.T. Sharpe (Eds.).
2. O'Connor PS, Tredici TJ, Ivan DJ, et al. Achromatopsia. Clinical diagnosis and treatment. J Clin Neuroophthalmol 1982, 2(4):219-226.
3. Thiadens AA, Somervuo V, Van Den Born LI, et al. Progressive loss of cones in achromatopsia: an imaging study using spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci 2010, 51(11):5952-5957.
4. Thiadens AA, Slingerland NW, Roosing S, et al. Genetic etiology and clinical consequences of complete and incomplete achromatopsia. Ophthalmology 2009, 116(10):1984-1989. e1981.
5. Thomas MG, Kumar A, Kohl S, et al. High-resolution in vivo imaging in achromatopsia. Ophthalmology 2011, 118(5):882-887.
6. Carroll J, Choi SS, Williams DR In vivo imaging of the photoreceptor mosaic of a rod monochromat. Vision Res 2008, 48(26):2564-2568.
7. Sundin OH, Yang JM, Li Y, et al. Genetic basis of total colourblindness among the Pingelapese islanders. Nat Genet 2000, 25(3):289-293.
8. Kohl S, Marx T, Giddings I, et al. Total colourblindness is caused by mutations in the gene encoding the alpha-subunit of the cone photoreceptor cGMP-gated cation channel. Nat Genet 1998, 19(3):257-259.
9. Wissinger B, Gamer D, Jagle H, et al. CNGA3 mutations in hereditary cone photoreceptor disorders. Am J Hum Genet 2001, 69(4):722-737.
10. Aligianis IA, Forshew T, Johnson S, et al. Mapping of a novel locus for achromatopsia (ACHM4) to 1p and identification of a germline mutation in the alpha subunit of cone transducin (GNAT2). J Med Genet 2002, 39(9):656-660.
11. Kohl S, Baumann B, Rosenberg T, et al. Mutations in the cone photoreceptor G-protein alpha-subunit gene GNAT2 in patients with achromatopsia. Am J Hum Genet 2002, 71(2):422-425.
12. Chang B, Grau T, Dangel S, et al. A homologous genetic basis of the murine cpfl1 mutant and human achromatopsia linked to mutations in the PDE6C gene. Proc Natl Acad Sci U S A 2009, 106(46):19581-19586.
13. Michaelides M, Aligianis IA, Holder GE, et al. Cone dystrophy phenotype associated with a frameshift mutation (M280fsX291) in the alpha-subunit of cone specific transducin (GNAT2). Br J Ophthalmol 2003, 87(11):1317-1320.
14. Park WL, Sunness JS Red contact lenses for alleviation of photophobia in patients with cone disorders. Am J Ophthalmol 2004, 137(4):774-775.
15. Alexander JJ, Umino Y, Everhart D, et al. Restoration of cone vision in a mouse model of achromatopsia. Nat Med 2007, 13(6):685-687.
16. Michalakis S, Muhlfriedel R, Tanimoto N, et al. Restoration of cone vision in the CNGA3-/- mouse model of congenital complete lack of cone photoreceptor function. Mol Ther Dec 2010, 18(12):2057-2063.
17. Komaromy AM, Alexander JJ, Rowlan JS, et al. Gene therapy rescues cone function in congenital achromatopsia. Hum Mol Genet Jul 1 2010, 19(13):2581-2593.
18. Pitt FHG Monochromatism. Nature 1944, 154:466-468.
19. Weale RA Cone-monochromatism. J Physiol 1953, 121(3):548-569.
20. Weale RA Photosensitive reactions in foveae of normal and cone-monochromatic observers. Opt Acta 1959, 6:158-174.
21. Gibson IM Visual mechanisms in a cone-monochromat. J Physiol 1962, 161:10P-11P.
22. Kellner U, Wissinger B, Tippmann S, et al. Blue cone monochromatism: clinical findings in patients with mutations in the red/green opsin gene cluster. Graefes Arch Clin Exp Ophthalmol 2004, 242(9):729-735.
23. Ayyagari R, Kakuk LE, Bingham EL, et al. Spectrum of color gene deletions and phenotype in patients with blue cone monochromacy. Hum Genet 2000, 107(1):75-82.
24. Ayyagari R, Kakuk LE, Coats CL, et al. Bilateral macular atrophy in blue cone monochromacy (BCM) with loss of the locus control region (LCR) and part of the red pigment gene. Mol Vis 28 1999, 5:13.
25. Berson EL, Sandberg MA, Rosner B, et al. Color plates to help identify patients with blue cone monochromatism. Am J Ophthalmol 1983, 95(6):741-747.
26. Weiss AH, Biersdorf WR Blue cone monochromatism. J Pediatr Ophthalmol Strabismus 1989, 26(5):218-223.
27. Alpern M, Lee GB, Maaseidvaag F, Miller SS Colour vision in blue-cone 'monochromacy. J Physiol 1971, 212(1):211-233.
28. Gouras P, MacKay CJ Electroretinographic responses of the short-wavelength-sensitive cones. Invest Ophthalmol Vis Sci 1990, 31(7):1203-1209.
29. Moskowitz A, Hansen RM, Akula JD, et al. Rod and rod-driven function in achromatopsia and blue cone monochromatism. Invest Ophthalmol Vis Sci 2009, 50(2):950-958.
30. Nathans J, Davenport CM, Maumenee IH, et al. Molecular genetics of human blue cone monochromacy. Science 1989, 245(4920):831-838.
31. Nathans J, Thomas D, Hogness DS Molecular genetics of human color vision: the genes encoding blue, green, and red pigments. Science 1986, 232(4747):193-202.
32. Nathans J, Maumenee IH, Zrenner E, et al. Genetic heterogeneity among blue-cone monochromats. Am J Hum Genet 1993, 53(5):987-1000.
33. Gardner JC, Michaelides M, Holder GE, et al. Blue cone monochromacy: causative mutations and associated phenotypes. Mol Vis 2009, 15:876-884.
34. Michaelides M, Johnson S, Simunovic MP, et al. Blue cone monochromatism: a phenotype and genotype assessment with evidence of progressive loss of cone function in older individuals. Eye (Lond) 2005, 19(1):2-10.
35. Zrenner E, Magnussen S, Lorenz B [Blue cone monochromasia: diagnosis, genetic counseling and optical aids]. Klin Monbl Augenheilkd 1988, 193(5):510-517.
36. Krill AE, Deutman AF, Fishman M The cone degenerations. Doc Ophthalmol 1973, 35(1):1-80.
37. Rowe SE, Trobe JD, Sieving PA Idiopathic photoreceptor dysfunction causes unexplained visual acuity loss in later adulthood. Ophthalmology 1990, 97(12):1632-1637.
38. Ladewig M, Kraus H, Foerster MH, Kellner U Cone dysfunction in patients with late-onset cone dystrophy and age-related macular degeneration. Arch Ophthalmol 2003, 121(11):1557-1561.
39. Sergouniotis PI, Holder GE, Robson AG, et al. High-resolution optical coherence tomography imaging in KCNV2 retinopathy. Br J Ophthalmol May 10, 2011, E-pub ahead of print, PMID21558291.
40. Wang NK, Chou CL, Lima LH, et al. Fundus autofluorescence in cone dystrophy. Doc Ophthalmol 2009, 119(2):141-144.
41. Duncan JL, Zhang Y, Gandhi J, et al. High-resolution imaging with adaptive optics in patients with inherited retinal degeneration. Invest Ophthalmol Vis Sci 2007, 48(7):3283-3291.
42. Kitiratschky VB, Grau T, Bernd A, et al. ABCA4 gene analysis in patients with autosomal recessive cone and cone rod dystrophies. Eur J Hum Genet 2008, 16(7):812-819.
43. Hamel CP Cone rod dystrophies. Orphanet J Rare Dis 2007, 2:7.
44. Rivolta C, Berson EL, Dryja TP Dominant Leber congenital amaurosis, cone-rod degeneration, and retinitis pigmentosa caused by mutant versions of the transcription factor CRX. Hum Mutat 2001, 18(6):488-498.
45. Kitiratschky VB, Nagy D, Zabel T, et al. Cone and cone-rod dystrophy segregating in the same pedigree due to the same novel CRX gene mutation. Br J Ophthalmol 2008, 92(8):1086-1091.
46. Maugeri A, Klevering BJ, Rohrschneider K, et al. Mutations in the ABCA4 (ABCR) gene are the major cause of autosomal recessive cone-rod dystrophy. Am J Hum Genet 2000, 67(4):960-966.
47. Nakazawa M, Kikawa E, Chida Y, et al. Autosomal dominant cone-rod dystrophy associated with mutations in codon 244 (Asn244His) and codon 184 (Tyr184Ser) of the peripherin/RDS gene. Arch Ophthalmol 1996, 114(1):72-78.
48. Demirci FY, Rigatti BW, Wen G, et al. X-linked cone-rod dystrophy (locus COD1): identification of mutations in RPGR exon ORF15. Am J Hum Genet 2002, 70(4):1049-1053.
49. Perrault I, Rozet JM, Gerber S, et al. A retGC-1 mutation in autosomal dominant cone-rod dystrophy. Am J Hum Genet 1998, 63(2):651-654.
50. Cunier R Historie d'une hemerolopie, hereditaire depuis siecles dans' un famille de la commune de Vendemian, pres Montpellier. Ann Soc Med de Gand 1838, 4:385.
51. Nettleship E A history of congenital stationary nightblindness in nine consecutive generations. Trans Ophthalmol Soc UK 1907, 27:269-293.
52. Carr RE Congenital stationary nightblindness. Trans Am Ophthalmol Soc 1974, 72:448-487.
53. Zeitz C, Labs S, Lorenz B, et al. Genotyping microarray for CSNB-associated genes. Invest Ophthalmol Vis Sci 2009, 50(12):5919-5926.
54. Rotenstreich Y, Harats D, Shaish A, et al. Treatment of a retinal dystrophy, fundus albipunctatus, with oral 9-cis-{beta}-carotene. Br J Ophthalmol 2010, 94(5):616-621.
55. Dryja TP Molecular genetics of Oguchi disease, fundus albipunctatus, and other forms of stationary night blindness: LVII Edward Jackson Memorial Lecture. Am J Ophthalmol 2000, 130(5):547-563.
56. Berson EL Retinitis pigmentosa. The Friedenwald Lecture. Invest Ophthalmol Vis Sci 1993, 34(5):1659-1676.
57. Miyake Y [Establishment of the concept of new clinical entities - complete and incomplete form of congenital stationary night blindness]. Nippon Ganka Gakkai Zasshi 2002, 106(12):737-755. discussion 756.
58. Strom TM, Nyakatura G, Apfelstedt-Sylla E, et al. An L-type calcium-channel gene mutated in incomplete X-linked congenital stationary night blindness. Nat Genet 1998, 19(3):260-263.
59. Sieving PA Photopic ON- and OFF-pathway abnormalities in retinal dystrophies. Trans Am Ophthalmol Soc 1993, 91:701-773.
60. Nakamura M, Ito S, Terasaki H, Miyake Y Novel CACNA1F mutations in Japanese patients with incomplete congenital stationary night blindness. Invest Ophthalmol Vis Sci 2001, 42(7):1610-1616.
61. Bech-Hansen NT, Naylor MJ, Maybaum TA, et al. Mutations in NYX, encoding the leucine-rich proteoglycan nyctalopin, cause X-linked complete congenital stationary night blindness. Nat Genet 2000, 26(3):319-323.
62. 2+-binding protein 4, cause autosomal recessive night blindness. Am J Hum Genet 2006, 79(4):657-667.
63. Dryja TP, McGee TL, Berson EL, et al. Night blindness and abnormal cone electroretinogram ON responses in patients with mutations in the GRM6 gene encoding mGluR6. Proc Natl Acad Sci U S A Mar 29 2005, 102(13):4884-4889.
64. Zeitz C, van Genderen M, Neidhardt J, et al. Mutations in GRM6 cause autosomal recessive congenital stationary night blindness with a distinctive scotopic 15-Hz flicker electroretinogram. Invest Ophthalmol Vis Sci 2005, 46(11):4328-4335.
65. Audo I, Kohl S, Leroy BP, et al. TRPM1 is mutated in patients with autosomal-recessive complete congenital stationary night blindness. Am J Hum Genet 2009, 85(5):720-729.
66. Li Z, Sergouniotis PI, Michaelides M, et al. Recessive mutations of the gene TRPM1 abrogate ON bipolar cell function and cause complete congenital stationary night blindness in humans. Am J Hum Genet 2009, 85(5):711-719.
67. Nakamura M, Sanuki R, Yasuma TR, et al. TRPM1 mutations are associated with the complete form of congenital stationary night blindness. Mol Vis 2010, 16:425-437.
68. van Genderen MM, Bijveld MM, Claassen YB, et al. Mutations in TRPM1 are a common cause of complete congenital stationary night blindness. Am J Hum Genet 2009, 85(5):730-736.
69. Oguchi C Ueber einen Fall von eigenartiger Hemeralopie. Nippon Ganka Gakkai Zasshi 1907, 11:123.
70. Mizuo G On a new discovery in the dark adaptation on Oguchi's dsease. Acta Soc Ophthalmol 1913, 17:1148.
71. Carr RE, Gouras P Oguchi's disease. Arch Ophthalmol 1965, 73:646-656.
72. Gouras P Electroretinography: Some basic principles. Invest Ophthalmol 1970, 9(8):557-569.
73. Kuwakara Y, Ishihara K, Akiya S Histopathological and electron microscopic studies of the reitna of Oguchi's disease. Acta Soc Ophthalmol Jpn 1963, 67:1323.
74. Hashimoto H, Kishi S Shortening of the rod outer segment in Oguchi disease. Graefes Arch Clin Exp Ophthalmol 2009, 247(11):1561-1563.
75. Yamada K, Motomura Y, Matsumoto CS, et al. Optical coherence tomographic evaluation of the outer retinal architecture in Oguchi disease. Jpn J Ophthalmol 2009, 53(5):449-451.
76. Fuchs S, Nakazawa M, Maw M, et al. A homozygous 1-base pair deletion in the arrestin gene is a frequent cause of Oguchi disease in Japanese. Nat Genet 1995, 10(3):360-362.
77. Yamamoto S, Sippel KC, Berson EL, et al. Defects in the rhodopsin kinase gene in the Oguchi form of stationary night blindness. Nat Genet 1997, 15(2):175-178.
78. Carr RE, Ripps H Rhodopsin kinetics and rod adaptation in Oguchi's disease. Invest Ophthalmol Vis Sci 1967, 6:426-436.
79. Carr RE, Ripps H, Siegel IM Visual pigment kinetics and adaptation in fundus albipunctatus. Doc Ophthalmol 1974, 193-204.
80. Nakamura M, Lin J, Miyake Y Young monozygotic twin sisters with fundus albipunctatus and cone dystrophy. Arch Ophthalmol 2004, 122(8):1203-1207.
81. Querques G, Carrillo P, Querques L, et al. High-definition optical coherence tomographic visualization of photoreceptor layer and retinal flecks in fundus albipunctatus associated with cone dystrophy. Arch Ophthalmol 2009, 127(5):703-706.
82. Genead MA, Fishman GA, Lindeman M Spectral-domain optical coherence tomography and fundus autofluorescence characteristics in patients with fundus albipunctatus and retinitis punctata albescens. Ophthalmic Genet 2010, 31(2):66-72.
83. Gonzalez-Fernandez F, Kurz D, Bao Y, et al. 11-cis retinol dehydrogenase mutations as a major cause of the congenital night-blindness disorder known as fundus albipunctatus. Mol Vis 30 1999, 5:41.
84. Yamamoto H, Simon A, Eriksson U, et al. Mutations in the gene encoding 11-cis retinol dehydrogenase cause delayed dark adaptation and fundus albipunctatus. Nat Genet 1999, 22(2):188-191.
85. Schatz P, Preising M, Lorenz B, et al. Fundus albipunctatus associated with compound heterozygous mutations in RPE65. Ophthalmology 2011, 118(5):888-894.
86. Voigt M, Querques G, Atmani K, et al. Analysis of retinal flecks in fundus flavimaculatus using high-definition spectral-domain optical coherence tomography. Am J Ophthalmol 2010, 150(3):330-337.
87. Niwa Y, Kondo M, Ueno S, et al. Cone and rod dysfunction in fundus albipunctatus with RDH5 mutation: an electrophysiological study. Invest Ophthalmol Vis Sci 2005, 46(4):1480-1485.
88. Maeda A, Maeda T, Palczewski K Improvement in rod and cone function in mouse model of fundus albipunctatus after pharmacologic treatment with 9-cis-retinal. Invest Ophthalmol Vis Sci 2006, 47(10):4540-4546.